Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

TPE/1731 stock hub

TPE/1731 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TPE/1731is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9B

Taiwan Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

TPE/1731

In the news

Latest news · TPE/1731

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12P50 15.5P75 22.5

Trailing P/E16

P25 14.4P50 18P75 31.9

ROE8.5

P25 -16.2P50 0.3P75 9.8

ROIC7.8

P25 -11.7P50 -0.2P75 8.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TPE/1731 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

TWD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Taiwan
Country code	TW
Employees	224
Enterprise value	TWD 2.9B
Exchange	Taiwan Stock Exchange
Financial currency	TWD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	TW0001731008
Last refreshed	2026-05-10
Market cap	TWD 2.9B
Price	TWD 21.7
Price currency	TWD
Rev Per Employee	7,071,718.75x
Sector	Healthcare
Sic	2834
Symbol	tpe/1731
Website	https://www.maywufa.com.tw

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.28%
EV Earnings	16.05x
EV/EBIT	14.47x
EV/EBITDA	11.38x
EV/FCF	14.11x
EV/Sales	1.83x
FCF yield	7.14%
P/B ratio	1.33x
P/E ratio	15.96x
P/S ratio	1.82x
PE Ratio10 Y	18.07x
PE Ratio3 Y	17.58x
PE Ratio5 Y	16.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	13.72%
EBITDA Margin	17.03%
FCF margin	13%
Gross margin	63.23%
Gross Profit	TWD 1B
Gross Profit Growth	4.15%
Gross Profit Growth Q	7.5%
Gross Profit Growth3 Y	7.05%
Gross Profit Growth5 Y	8.17%
Net Income	TWD 181M
Net Income Growth	4.49%
Net Income Growth Q	22.02%
Net Income Growth Quarters	3%
Net Income Growth Years	3%
Net Income Growth3 Y	3.8%
Net Income Growth5 Y	1.14%
Pretax Margin	14.43%
Profit Margin	11.43%
Profit Per Employee	TWD 808,045
Profitable Years	17
ROA	4.24
Roa5y	4.62
ROCE	7.75
ROE	8.48
Roe5y	8.35
ROIC	7.84
Roic5y	9.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	9.54%
Cagr15y	5.75%
Cagr1y	0.15%
Cagr20y	7.86%
Cagr3y	3.81%
Cagr5y	7.48%
Div CAGR10	7.18%
Div CAGR3	0.85%
Div CAGR5	14.87%
EPS Growth	4.62
EPS Growth Q	22.02
EPS Growth Quarters	1
EPS Growth Years	3
EPS Growth3 Y	3.97
EPS Growth5 Y	1.22
FCF Growth5 Y	13.58%
OCF Growth	3.5%
OCF Growth Q	44.23%
OCF Growth10 Y	3.68%
OCF Growth3 Y	14.71%
OCF Growth5 Y	-1.48%
Revenue Growth	6.61x
Revenue Growth Q	10.3x
Revenue Growth Quarters	9x
Revenue Growth Years	3x
Revenue Growth3 Y	8.36x
Revenue Growth5 Y	8.26x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	TWD 0.49
Assets	TWD 3.2B
Cash	TWD 620.1M
Current Assets	TWD 1.2B
Current Liabilities	TWD 433.2M
Debt	TWD 641.8M
Debt EBITDA	TWD 2.36
Debt Equity	TWD 0.3
Debt FCF	TWD 3.12
Equity	TWD 2.2B
Interest Coverage	26.23
Liabilities	TWD 1.1B
Long Term Assets	TWD 2B
Long Term Liabilities	TWD 641.3M
Net Cash	TWD -21.7M
Net Cash By Market Cap	TWD -0.75
Net Debt EBITDA	TWD 0.08
Net Debt Equity	TWD 0.01
Net Debt FCF	TWD 0.11
Tangible Book Value	TWD 2.2B
Tangible Book Value Per Share	TWD 16.22
WACC	4.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Inventory Turnover	2.01
Net Working Capital	TWD 158.6M
Quick ratio	2.1
Working Capital	TWD 776.3M
Working Capital Turnover	TWD 2.14

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.03%
Dividend Growth	4.35%
Dividend Growth Years	2%
Dividend per share	TWD 1.22
Dividend Years	24
Dividend Yield	5.62%
Ex Div Date	2025-06-30
Last Dividend	TWD 1.2
Payout Frequency	Annual
Payout Ratio	88.12%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	148.63%
1Y total return	0.15%
200-day SMA	21.83
3Y total return	11.88%
50-day SMA	21.83
50-day SMA vs 200-day SMA	50under200
5Y total return	43.44%
All Time High	30.29
All Time High Change	-28.37%
All Time High Date	2007-07-26
All Time Low	7.85
All Time Low Change	176.33%
All Time Low Date	2006-09-19
ATR	0.15
Beta	0.1
Beta1y	0.09
Beta2y	0.23
Ch YTD	-0.23
High	21.8
High52	23.5
High52 Date	2025-06-18
High52ch	-7.66%
Low	21.6
Low52	21.5
Low52 Date	2025-09-02
Low52ch	0.93%
Ma50ch	-0.57%
Price vs 200-day SMA	-0.58%
RSI	46.01
RSI Monthly	46.25
RSI Weekly	41.14
Sharpe ratio	0.17x
Sortino ratio	1.23
Total Return	5.6%
Tr YTD	-0.23
Tr15y	131.34%
Tr1w	0.23%
Tr3m	-0.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	TWD 217.4M
Operating Income Growth	4.68
Operating Income Growth Q	10.24
Operating Income Growth3 Y	2.96
Operating Income Growth5 Y	4.97
Operating margin	13.72

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	64,423,414%
Net Borrowing	-36,977,000
Shares Insiders	6.68%
Shares Institutions	0.39%
Shares Out	132,915,244
Shares Qo Q	0.36%
Shares Yo Y	0.03%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	TWD 206M
Average Volume	115,208.85x
Bv Per Share	16.27
CAPEX	TWD -17.3M
Ch10y	57.82
Ch15y	26.9
Ch1w	0.23
Ch1y	-5.03
Ch20y	129.1
Ch3m	-0.69
Ch3y	-3.12
Ch5y	10.71
Ch6m	-0.91
Change	-0.23%
Change From Open	-0.46
Close	21.75
Days Gap	0.23
Depreciation Amortization	52,364,000
Dollar Volume	3,215,657.9
Earnings Date	2026-05-14
EBIT	TWD 217.4M
EBITDA	TWD 269.7M
EPS	TWD 1.36
F Score	5
FCF	TWD 206M
FCF EV Yield	7.09x
FCF Per Share	TWD 1.55
Financing CF	-196,474,000
Fiscal Year End	December
Founded	1,976
Graham Number	22.31491
Graham Upside	2.83
Income Tax	TWD 47.6M
Investing CF	22,123,000
Is Primary Listing	1
Last Earnings Date	2026-03-03
Last Report Date	2025-12-31
Last Split Date	2010-07-27
Last Split Type	Forward
Lynch Fair Value	TWD 6.8
Lynch Upside	-68.66
Ma150	21.85
Ma150ch	-0.67%
Ma20	21.76
Ma20ch	-0.25%
Net CF	49,695,000
Next Earnings Date	2026-05-14
Open	21.8
P FCF Ratio	14
P OCF Ratio	12.92
Payment Date	2025-07-24
Position In Range	50
Ppne	1,241,814,000
Price Date	2026-05-08
Price EBITDA	TWD 10.69
Ptbv Ratio	1.34
Relative Volume	1.35x
Revenue	1,584,065,000x
Tax By Revenue	3x
Tax Rate	20.81%
Tr20y	354.2%
Tr6m	-0.91%
Volume	148,187
Z Score	2.95

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

TPE/1731 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+5.6%

$1.22 annual per share

Payout ratio

+88.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+14.9%

2 consecutive years of growth

Total shareholder yield

+5.6%

Next ex-dividend date: 2025-06-30

Performance

TPE/1731 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TPE/1731?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.4%

Share of float held by funds and institutions

Insider ownership

+6.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.0%

Negative means the company is buying back shares.

Technical

TPE/1731 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.0

Neutral momentum band

Price vs 200-day MA

-0.6%

50/200-day relationship not available

Beta (5Y)

0.10

Less volatile than the market

Sharpe ratio

0.17

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TPE/1731

Hub-level FAQ points readers to the deeper analysis pages.

What is the current tpe/1731 stock rating?

tpe/1731 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full tpe/1731 analysis?

The full report lives at /stocks/tpe/1731/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for tpe/1731?

The latest report frames tpe/1731 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the tpe/1731 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.